These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 21048202)

  • 1. FDA approves mannitol bronchial-challenge test kit.
    Thompson CA
    Am J Health Syst Pharm; 2010 Nov; 67(22):1886. PubMed ID: 21048202
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacologic substances for bronchial provocation testing].
    Ferlinz R
    Internist (Berl); 1997 Aug; 38(8):778-9. PubMed ID: 9378625
    [No Abstract]   [Full Text] [Related]  

  • 3. [Is the bronchial provocation test a provocation?].
    Nolte D
    Med Klin (Munich); 1997 Aug; 92(8):492-3. PubMed ID: 9340474
    [No Abstract]   [Full Text] [Related]  

  • 4. Provocative challenges to help diagnose and monitor asthma: exercise, methacholine, adenosine, and mannitol.
    Anderson SD
    Curr Opin Pulm Med; 2008 Jan; 14(1):39-45. PubMed ID: 18043274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methodology of bronchial responsiveness.
    Chinn S
    Thorax; 1998 Nov; 53(11):984-8. PubMed ID: 10193400
    [No Abstract]   [Full Text] [Related]  

  • 6. [Recommendations for implementing bronchial provocation tests with pharmacologic substances. German Society of Pneumology--Scientific "Bronchial Provocation Tests" Study Group].
    Klein G
    Med Klin (Munich); 1997 Aug; 92(8):458-63. PubMed ID: 9340468
    [No Abstract]   [Full Text] [Related]  

  • 7. [Bronchial challenges in asthma diagnosis].
    Sak I; Kurzawa R; Nowosielska A
    Przegl Lek; 2005; 62(12):1488-93. PubMed ID: 16786780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999.
    Crapo RO; Casaburi R; Coates AL; Enright PL; Hankinson JL; Irvin CG; MacIntyre NR; McKay RT; Wanger JS; Anderson SD; Cockcroft DW; Fish JE; Sterk PJ
    Am J Respir Crit Care Med; 2000 Jan; 161(1):309-29. PubMed ID: 10619836
    [No Abstract]   [Full Text] [Related]  

  • 9. Asthma monitoring in primary care: time to gather more robust evidence.
    Beilby J
    Prim Care Respir J; 2012 Mar; 21(1):4-5. PubMed ID: 22273630
    [No Abstract]   [Full Text] [Related]  

  • 10. The pharmacology of aerosolized airway challenge.
    Wagers SS; Irvin CG
    Respir Care Clin N Am; 1999 Dec; 5(4):633-48. PubMed ID: 10565885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The study of bronchial hyperreactivity in children].
    Fayon MJ
    Rev Mal Respir; 1998 Feb; 15(1):8-9. PubMed ID: 9551509
    [No Abstract]   [Full Text] [Related]  

  • 12. Bronchial hyperresponsiveness: definition and terminology.
    Sterk PJ
    Pediatr Allergy Immunol; 1996; 7(9 Suppl):7-9. PubMed ID: 9156734
    [No Abstract]   [Full Text] [Related]  

  • 13. The safety and efficacy of inhaled dry powder mannitol as a bronchial provocation test for airway hyperresponsiveness: a phase 3 comparison study with hypertonic (4.5%) saline.
    Brannan JD; Anderson SD; Perry CP; Freed-Martens R; Lassig AR; Charlton B;
    Respir Res; 2005 Dec; 6(1):144. PubMed ID: 16336673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Airway hyperresponsiveness to mannitol and methacholine and exhaled nitric oxide: a random-sample population study.
    Sverrild A; Porsbjerg C; Thomsen SF; Backer V
    J Allergy Clin Immunol; 2010 Nov; 126(5):952-8. PubMed ID: 20934208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of bronchial hyperreactivity with mannitol dry powder challenge test in a paediatric population with intermittent allergic asthma or allergic rhinitis.
    Decimo F; Capristo C; Amelio R; Maiello N; Capristo AF; Miraglia Del Giudice M
    Int J Immunopathol Pharmacol; 2011; 24(4):1069-74. PubMed ID: 22230412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bronchial provocation testing: the future.
    Anderson SD; Brannan JD
    Curr Opin Allergy Clin Immunol; 2011 Feb; 11(1):46-52. PubMed ID: 21150437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methacholine dry powder inhaler as a new tool for bronchial challenge test.
    Colombo G; Terzano C; Colombo P; Petroianni A; Ricci A; Buttini F
    Int J Pharm; 2008 Mar; 352(1-2):165-71. PubMed ID: 18055141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The bronchial response to mannitol is attenuated by a previous methacholine test: but not vice versa.
    Gade E; Thomsen SF; Porsbjerg C; Backer V
    Clin Exp Allergy; 2009 Jul; 39(7):966-71. PubMed ID: 19489848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of central and peripheral airway involvement before and during methacholine, mannitol and eucapnic hyperventilation challenges in mild asthmatics.
    Aronsson D; Tufvesson E; Bjermer L
    Clin Respir J; 2011 Jan; 5(1):10-8. PubMed ID: 21159136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhaled Mannitol as a Laryngeal and Bronchial Provocation Test.
    Tay TR; Hoy R; Richards AL; Paddle P; Hew M
    J Voice; 2017 Mar; 31(2):247.e19-247.e23. PubMed ID: 27567392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.